Alyeska Investment Group
ACET icon

Alyeska Investment Group’s Adicet Bio ACET Stock Holding History

Alyeska Investment Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Hold
203,799
– – ﹤0.01% 579
2026
Q1 		$1.39M Hold
203,799
– – ﹤0.01% 562
2025
Q4 		$1.72M Buy
203,799
+162,820
+397% +$1.8M ﹤0.01% 526
2025
Q3 		$531K Hold
40,979
– – ﹤0.01% 560
2025
Q2 		$400K Hold
40,979
– – ﹤0.01% 525
2025
Q1 		$495K Hold
40,979
– – ﹤0.01% 469
2024
Q4 		$631K Hold
40,979
– – ﹤0.01% 512
2024
Q3 		$944K Hold
40,979
– – ﹤0.01% 466
2024
Q2 		$793K Hold
40,979
– – ﹤0.01% 478
2024
Q1 		$1.54M Buy
+40,979
New +$1.7M 0.01% 395
2019
Q2 		– Sell
-1,339
Closed -$1.02M – 430
2019
Q1 		$1.02M Buy
+1,339
New +$1.22M 0.01% 315

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Alyeska Investment Group's ACET Position: Q2 2026 in Review

Alyeska Investment Group held its Adicet Bio (ACET) position steady in Q2 2026 at 203,799 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Alyeska Investment Group first reported a position in ACET in Q1 2019 and has held it in 11 quarters since. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Alyeska Investment Group held 203,799 shares of Adicet Bio worth $1.76M as of Q2 2026.
  • Alyeska Investment Group left its Adicet Bio share count unchanged in Q2 2026.
  • Adicet Bio made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #579 holding.
  • Alyeska Investment Group first reported a position in Adicet Bio in Q1 2019 and has held it in 11 quarters since.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.